Are localized prostate cancer biomarkers useful in the clinical practice?
Prostate cancer presents itself in a heterogeneous way with both aggressive and indolent forms. Despite the controversy surrounding its use, prostate-specific antigen screening ultimately leads to a greater number of diagnosed patients. One of the biggest challenges in clinical practice is to select...
Saved in:
| Main Authors: | Arie Carneiro, Paulo Priante Kayano, Álan Roger Gomes Barbosa, Marcelo Langer Wroclawski, Carolina Ko Chen, Giulio Costa Cavlini, Guilherme Jose Reche, Rafael Sanchez-Salas, Marcos Tobias-Machado, Adam G Sowalsky, Bianca Bianco |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2018-09-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428318799255 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Defining minimal invasive surgical therapy for benign prostatic obstruction surgery: Perspectives from a global knowledge, attitude, and practice survey
by: Bryan Kwun-Chung Cheng, et al.
Published: (2024-01-01) -
Transperineal laser ablation of the prostate as a treatment for benign prostatic hyperplasia and prostate cancer: The results of a Delphi consensus project
by: Andrea Cocci, et al.
Published: (2024-04-01) -
Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus
by: Shahana Sarwar, et al.
Published: (2017-01-01) -
The value of post radiotherapy prostate specific antigen dynamics for prostate cancer risk stratification models
by: Jane Shortall, et al.
Published: (2025-04-01) -
Neural crosstalk and symptom overlap: The correlation between urinary and intestinal symptoms in patients undergoing colonoscopy
by: Pedro Henrique P. Costa, et al.
Published: (2025-05-01)